The Covid-19 vaccine Convidecia received its emergency approval on Thursday from the World Health Organization.
It was designed by CanSino Biologics laboratories, and hits the market as Beijing battles a resurgence of the pandemic.
This vaccine is based on a modified human adenovirus, it is administered in a single dose and the WHO recommends it for all age groups from 18 years old, specifies a press release from the WHO.
World
Covid-19 in China: Shanghai announces zero cases of coronavirus but remains in containment
World
North Korea: Eight new deaths from Covid-19, Kim Jong-un castigates health authorities
Health
Coronavirus
Covid vaccine
China